These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11231726)

  • 1. Dalteparin vs warfarin in hip arthroplasty patients.
    Bajjoka AE
    Arch Intern Med; 2001 Mar; 161(5):776-8. PubMed ID: 11231726
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin.
    Francis CW; Pellegrini VD; Totterman S; Boyd AD; Marder VJ; Liebert KM; Stulberg BN; Ayers DC; Rosenberg A; Kessler C; Johanson NA
    J Bone Joint Surg Am; 1997 Sep; 79(9):1365-72. PubMed ID: 9314399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin.
    Chillag KJ
    J Bone Joint Surg Am; 1998 Aug; 80(8):1245-6. PubMed ID: 9730137
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin.
    Hoek KJ
    J Bone Joint Surg Am; 1998 Aug; 80(8):1246. PubMed ID: 9730138
    [No Abstract]   [Full Text] [Related]  

  • 5. [Economic analysis of dalteparin use in knee surgery at Instituto Mexicano del Seguro Social].
    Arreola-Ornelas H; Rosado-Buzzo A; García-Mollinedo L; Dorantes Aguilar J; Muciño-Ortega E; Mould-Quevedo JF
    Cir Cir; 2012; 80(5):411-8. PubMed ID: 23351443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into extended prophylaxis after orthopaedic surgery - the North American Fragmin Trial experience.
    Hull RD
    Haemostasis; 2000; 30 Suppl 2():95-100; discussion 82-3. PubMed ID: 11251350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators.
    Hull RD; Pineo GF; Francis C; Bergqvist D; Fellenius C; Soderberg K; Holmqvist A; Mant M; Dear R; Baylis B; Mah A; Brant R
    Arch Intern Med; 2000 Jul; 160(14):2199-207. PubMed ID: 10904464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended travel after hip arthroplasty surgery. Is it safe?
    Ball ST; Pinsorsnak P; Amstutz HC; Schmalzried TP
    J Arthroplasty; 2007 Sep; 22(6 Suppl 2):29-32. PubMed ID: 17823011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dalteparin in critically ill patients.
    Smythe MA; Koerber JM
    N Engl J Med; 2011 Jul; 365(2):179-80; author reply 180. PubMed ID: 21751919
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators.
    Hull RD; Pineo GF; Francis C; Bergqvist D; Fellenius C; Soderberg K; Holmqvist A; Mant M; Dear R; Baylis B; Mah A; Brant R
    Arch Intern Med; 2000 Jul; 160(14):2208-15. PubMed ID: 10904465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP; Bounameaux H
    Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dalteparin compared with an oral anticoagulant for thromboprophylaxis in patients with cancer.
    Kaufman JL
    N Engl J Med; 2003 Oct; 349(14):1385-7; author reply 1385-7. PubMed ID: 14526769
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
    Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M;
    N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of deep venous thrombosis prophylaxis after hip fracture.
    Wade WE; Chisholm MA
    Am J Orthop (Belle Mead NJ); 2000 May; 29(5):397-9. PubMed ID: 10868442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dalteparin new treatment duration: new dosage. Is prolonged prophylaxis needed?
    Prescrire Int; 2000 Feb; 9(45):197-8. PubMed ID: 11503794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summaries for patients. Ximelagatran versus warfarin to prevent blood clots after knee replacement surgery.
    Ann Intern Med; 2002 Oct; 137(8):I38. PubMed ID: 12379093
    [No Abstract]   [Full Text] [Related]  

  • 17. Warfarin prophylaxis for orthopaedic venous thromboembolic disease.
    Pellegrini VD
    Instr Course Lect; 2002; 51():491-8. PubMed ID: 12064139
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
    Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ;
    Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alopecia and dalteparin: a previously unreported association.
    Barnes C; Deidun D; Hynes K; Monagle P
    Blood; 2000 Aug; 96(4):1618-9. PubMed ID: 10979669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.